Bordeaux, France

Jean-Claude Emperaire

This inventor holds 2 USPTO granted patents. Top assignee: Applied Research Systems Ars Holding N.v.. Active years: 2002-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Claude Emperaire. Retrieved from https://idiyas.com/inventor/jean-claude-emperaire

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jean-Claude Emperaire

Introduction

Jean-Claude Emperaire is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of medicine, particularly in the area of reproductive health. With a total of 2 patents, his work focuses on developing effective medicaments for initiating ovulation.

Latest Patents

Emperaire's latest patents include innovative formulations aimed at enhancing ovulation. One of his key inventions is a medicament for initiating ovulation that comprises LH in an administrable form. This formulation ensures an increase in LH plasma levels for a period of approximately 40 to 60 hours. Another patent addresses ovulation-triggering drugs, which also utilize LH to achieve similar results. These advancements have the potential to significantly impact fertility treatments.

Career Highlights

Jean-Claude Emperaire is associated with Applied Research Systems Ars Holding N.V., where he continues to develop and refine his inventions. His dedication to research and innovation has positioned him as a valuable contributor to the field of reproductive medicine.

Conclusion

Jean-Claude Emperaire's work exemplifies the importance of innovation in healthcare. His patents reflect a commitment to improving reproductive health through scientific advancements. The impact of his inventions may lead to better outcomes for individuals seeking fertility solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…